TSG101 and endometrial cancer: Furthermore, an attempt to investigate the usefulness of the loss of TSG101 expression as a possible diagnostic marker for endometrial cancer showed 68% sensitivity and 68% specificity (AUC = 0.75; p = 0.0002), with a cut-off of 25% of cells expressing this marker.